17122-69-9 Usage
Uses
Used in Pharmaceutical Industry:
N-(3,4-Dimethylphenyl)-2-(hydroxyimino)acetamide is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and properties make it a valuable component in the development of new medications.
Used in Antimicrobial Applications:
In the field of microbiology, N-(3,4-Dimethylphenyl)-2-(hydroxyimino)acetamide is utilized for its antimicrobial properties. It can potentially be incorporated into formulations to combat a range of microbial infections.
Used in Anti-inflammatory Applications:
N-(3,4-Dimethylphenyl)-2-(hydroxyimino)acetamide is also used in the development of anti-inflammatory agents. Its potential to reduce inflammation could be harnessed in the treatment of various conditions characterized by inflammation.
While the specific applications in different industries are not detailed in the provided materials, the above uses are inferred based on the compound's known properties and potential. Further research would be required to delineate specific applications and industries where N-(3,4-Dimethylphenyl)-2-(hydroxyimino)acetamide could be effectively utilized.
Check Digit Verification of cas no
The CAS Registry Mumber 17122-69-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,2 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 17122-69:
(7*1)+(6*7)+(5*1)+(4*2)+(3*2)+(2*6)+(1*9)=89
89 % 10 = 9
So 17122-69-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O2/c1-7-3-4-9(5-8(7)2)12-10(13)6-11-14/h3-6,14H,1-2H3,(H,12,13)/b11-6+
17122-69-9Relevant academic research and scientific papers
4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM
-
Page/Page column 375, (2008/06/13)
The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides 4,4-(disubstituted)piperidine derivatives represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.
PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM
-
Page 457, (2008/06/13)
The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.
